(USD) | Mar 2023 | Q/Q |
---|---|---|
Revenue | 9.7B | -3% |
Gross Profit | 5.4B | - |
Cost Of Revenue | 4.3B | -6% |
Operating Income | 1.5B | +16% |
Operating Expenses | 3.9B | - |
Net Income | 1.3B | +28% |
R&D | 654MM | -10% |
G&A | 2.8B | -7% |
Amortization | 491MM | -1% |
Interest Expense | 153MM | -1% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Abbott stock jumped Thursday after showing patients taking popular diabetes and weight-loss drugs are more compliant with their CGMs.
Abbott's (ABT) Nutrition business has started showing signs of recovery since the beginning of 2023.
Key Insights Abbott Laboratories' estimated fair value is US$130 based on 2 Stage Free Cash Flow to Equity Abbott...
The heavy selling pressure might have exhausted for Abbott (ABT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Alphabet, Exxon Mobil, Merck, Abbott Laboratories and NextEra Energy are part of the Zacks top Analyst Blog.
Abbott (ABT) closed at $95.53 in the latest trading session, marking a -0.73% move from the prior day.
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Exxon Mobil Corp. (XOM) and Merck & Co., Inc. (MRK).
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Abbott (NYSE: ABT) will announce its third-quarter 2023 financial results on Wednesday, Oct. 18, before the market opens.
In this article, we discuss 15 best dividend aristocrat stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Dividend Aristocrat Stocks To Buy Now. Dividend Aristocrats are a select group of publicly traded companies in the S&P 500 that have raised […]